Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Carnegie Fund - Medical Sub-Fund

+ Add to Watchlist

CFE4:GR

103.3110 EUR 0.2790 0.27%

As of 02:33:04 ET on 01/30/2015.

Snapshot for Carnegie Fund - Medical Sub-Fund (CFE4)

Open: 103.3110 High - Low: 103.3110 - 103.3110 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 67.1800 - 105.2270 Beta vs DAX: 0.6355

ETF Chart for CFE4

No chart data available.
  • CFE4:GR 103.3110
  • 1D
  • 1M
  • 1Y
103.5900
Interactive CFE4 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CFE4

Carnegie Fund - Medical Sub-Fund is an FCP incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests globally in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors.

Inception Date: Telephone: 352-40-40-30-1
Managers: ANGELICA FATOUROS
Web Site: www.carnegieam.com

Fundamentals for CFE4

NAV (on 2015-01-30) 104.8300
Assets (M) (on 2014-12-31) 617.0211
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -1.45
Average 52-Week % Premium -0.8073
Fund Leveraged N

Dividends for CFE4

No dividends reported

Performance for CFE4

1-Month +9.78% 1-Year +44.90%
3-Month +14.73% 3-Year +31.03%
Year To Date +9.78% 5-Year +21.16%
Expense Ratio -

Top Fund Holdings for CFE4

Filing Date: 12/31/2014
Name Position Value % of Total
Gilead Sciences Inc 529,672 42,255,774 6.848%
Johnson & Johnson 363,186 31,773,157 5.149%
Carnegie Fund V - The Carnegie 108,460 31,590,098 5.120%
Novartis AG 410,862 31,556,142 5.114%
Amgen Inc 228,638 30,603,275 4.960%
Roche Holding AG 128,741 28,898,200 4.684%
UnitedHealth Group Inc 329,158 28,111,902 4.556%
Pfizer Inc 1,036,315 26,957,357 4.369%
Celgene Corp 283,838 26,772,707 4.339%
Biogen Idec Inc 82,892 23,629,110 3.830%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil